Journey Medical Corporation (DERM)

NASDAQ: DERM · Real-Time Price · USD

5.19

+0.05 (0.97%)

Feb 21, 2025, 4:00 PM EST - Market closed

Journey Medical Employees

Journey Medical had 41 employees as of December 31, 2023. The number of employees increased by 21 or 105.00% compared to the previous year.

Employees

41

Change (1Y)

21

Growth (1Y)

105.00%

Revenue / Employee

$1,409,049

Profits / Employee

-$447,220

Market Cap

108.42M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	41	21	105.00%
Dec 31, 2022	20	-70	-77.78%
Dec 31, 2021	90	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	122,000
Abbott Laboratories	114,000
AstraZeneca	89,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	72,000

Employee Rankings

DERM News

17 days ago - Stock Picks From Seeking Alpha's January 2025 New Analysts - Seeking Alpha
23 days ago - Journey Medical Corporation: Emrosi's Launch Could Be A Turning Point - Seeking Alpha
4 weeks ago - Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - GlobeNewsWire
3 months ago - Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
3 months ago - Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - GlobeNewsWire
4 months ago - Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference - GlobeNewsWire
5 months ago - Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
5 months ago - Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - GlobeNewsWire